Roche Aktie
293,60
EUR
+0,60
EUR
+0,20
%
293,80
EUR
±0,00
EUR
±0,00
%
Werbung
Roche Aktie Analyse
| 25.02.13 | Roche kaufen | S&P Equity Research | |
| 22.02.13 | Roche halten | Citigroup Corp. | |
| 05.02.13 | Roche halten | Hamburger Sparkasse AG (Haspa) | |
| 01.02.13 | Roche kaufen | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 31.01.13 | Roche kaufen | Barclays Capital | |
| 30.01.13 | Roche kaufen | S&P Equity Research | |
| 28.01.13 | Roche kaufen | S&P Equity Research | |
| 12.12.12 | Roche outperform | Credit Suisse Group | |
|
Werbung
|
|||
| 12.12.12 | Roche buy | Deutsche Bank AG | |
| 11.12.12 | Roche outperform | Exane-BNP Paribas SA | |
| 11.12.12 | Roche halten | Norddeutsche Landesbank (Nord/LB) | |
| 05.12.12 | Roche overweight | J.P. Morgan Cazenove | |
| 30.11.12 | Roche buy | Sarasin Research | |
| 30.11.12 | Roche outperform | Sanford C. Bernstein and Co., Inc. | |
| 05.11.12 | Roche neutral | Citigroup Corp. | |
| 24.10.12 | Roche buy | Sarasin Research | |
| 18.10.12 | Roche outperform | Credit Suisse Group | |
| 18.10.12 | Roche overweight | J.P. Morgan Cazenove | |
| 18.10.12 | Roche halten | Hamburger Sparkasse AG (Haspa) | |
| 17.10.12 | Roche outperform | Exane-BNP Paribas SA | |
| 16.10.12 | Roche outperform | Cheuvreux SA | |
| 16.10.12 | Roche buy | Banc of America Securities-Merrill Lynch | |
| 15.10.12 | Roche buy | Sarasin Research | |
| 12.10.12 | Roche outperform | Exane-BNP Paribas SA | |
| 12.10.12 | Roche neutral | Nomura | |
| 12.10.12 | Roche outperform | Credit Suisse Group | |
| 11.10.12 | Roche buy | Deutsche Bank AG | |
| 05.10.12 | Roche kaufen | Fuchsbriefe | |
| 04.10.12 | Roche outperform | Cheuvreux SA | |
| 02.10.12 | Roche neutral | Nomura | |
| 02.10.12 | Roche overweight | J.P. Morgan Cazenove | |
| 02.10.12 | Roche outperform | Exane-BNP Paribas SA | |
| 27.09.12 | Roche neutral | UBS AG | |
| 11.09.12 | Roche outperform | Sanford C. Bernstein and Co., Inc. | |
| 10.09.12 | Roche buy | Banc of America Securities-Merrill Lynch | |
| 07.09.12 | Roche outperform | Exane-BNP Paribas SA | |
| 06.09.12 | Roche overweight | J.P. Morgan Cazenove | |
| 06.09.12 | Roche buy | Sarasin Research | |
| 03.09.12 | Roche outperform | Credit Suisse Group | |
| 31.08.12 | Roche buy | Deutsche Bank AG | |
| 28.08.12 | Roche buy | Deutsche Bank AG | |
| 27.08.12 | Roche buy | Sarasin Research | |
| 24.08.12 | Roche overweight | J.P. Morgan Cazenove | |
| 27.07.12 | Roche outperform | Exane-BNP Paribas SA | |
| 25.07.12 | Roche kaufen | Sarasin Research | |
| 17.07.12 | Roche buy | Deutsche Bank AG | |
| 12.07.12 | Roche neutral | J.P. Morgan Cazenove | |
| 28.06.12 | Roche buy | Deutsche Bank AG | |
| 22.06.12 | Roche neutral | Nomura | |
| 20.06.12 | Roche neutral | Citigroup Corp. | |
Werbung
Werbung